AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 177 filers reported holding AXSOME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,500,371 | -2.7% | 50,084 | 0.0% | 0.02% | -3.8% |
| Q2 2023 | $3,599,036 | -33.3% | 50,084 | -47.3% | 0.03% | -29.7% |
| Q1 2023 | $5,398,114 | -59.2% | 95,084 | -44.5% | 0.04% | -58.4% |
| Q4 2022 | $13,225,170 | +168.5% | 171,474 | +55.3% | 0.09% | +154.3% |
| Q3 2022 | $4,925,000 | +11.7% | 110,380 | -4.1% | 0.04% | -2.8% |
| Q2 2022 | $4,408,000 | -7.5% | 115,084 | 0.0% | 0.04% | +12.5% |
| Q1 2022 | $4,763,000 | +33.6% | 115,084 | +22.0% | 0.03% | +39.1% |
| Q4 2021 | $3,565,000 | -29.6% | 94,357 | -38.6% | 0.02% | -32.4% |
| Q3 2021 | $5,063,000 | -36.7% | 153,602 | +29.5% | 0.03% | -38.2% |
| Q2 2021 | $8,001,000 | -11.7% | 118,602 | +2.4% | 0.06% | -26.7% |
| Q1 2021 | $9,062,000 | -4.0% | 115,802 | 0.0% | 0.08% | 0.0% |
| Q4 2020 | $9,435,000 | +31.8% | 115,802 | +15.3% | 0.08% | +11.9% |
| Q3 2020 | $7,157,000 | – | 100,455 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |